. CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology. 2008 May 6;70(19 Pt 2):1827-35. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(19)
265.24 ± 110.72
pg/mL
ELISA;
Other/Not Specified;
In-house
Aβ42
(CSF)
CTRL-
CNC
(13)
429.46 ± 133.83
pg/mL
ELISA;
Other/Not Specified;
In-house
Aβ42
(CSF)
FTD
(19)
533.42 ± 316.24
pg/mL
ELISA;
Other/Not Specified;
In-house
tau-total
(CSF)
AD
(19)
522.56 ± 291.89
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
CTRL-
CNC
(13)
260.42 ± 93.75
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
FTD
(19)
271.9 ± 149.81
pg/mL
ELISA;
Innotest;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.